Cremieux | How China Won the Clinical Trial Race, Gene Therapy, US Biotech's Blind Spot Live on MTS

Cremieux joins MTS to discuss China's rapid ascent to the top of global clinical trial output, the structural regulatory reforms that drove it, and what the US would need to do to close the gap. He covers novel gene therapy pipelines, the market authorization holder system, and why pharmaceutical profit margins may be the biggest bottleneck to American biomedical innovation.--MTS is a live news and interview show covering technology, business, politics, and culture as it happens.Follow MTS:X | ⁠⁠⁠⁠⁠https://twitter.com/MTSlive⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube | ⁠⁠⁠⁠⁠https://www.youtube.com/@mtsituation⁠⁠⁠⁠⁠Spotify | ⁠⁠⁠⁠⁠https://open.spotify.com/show/4HUNNmV1pjV7CW6Lphm1rM⁠⁠⁠Apple | ⁠⁠⁠⁠⁠https://podcasts.apple.com/us/podcast/mts/id1891088763⁠⁠⁠⁠⁠ Substack | ⁠⁠⁠⁠⁠https://mtslive.substack.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Interested in sponsoring the show? ⁠⁠⁠⁠⁠[email protected]⁠⁠--Brought to you by:Granola - The AI notepad. Try it once and never go back. ⁠https://granola.ai/mts⁠Kong - The AI connectivity platform. Connect APIs, LLMs, agents, and systems with serious security and governance. ⁠https://konghq.com⁠Blitzy - Autonomous software development for enterprise codebases. Ship 5x faster. ⁠https://blitzy.com⁠Merge - OpenAI, Dropbox, and Ramp use Merge to get AI to production faster. ⁠https://merge.dev/mts⁠AdQuick - Make your brand a billboard. Out-of-home advertising as easy to scale as digital. ⁠https://adquick.com⁠Macroscope - AI codebase understanding for engineering leaders. ⁠https://macroscope.com/mts⁠--Note: This podcast is not investment, legal, or tax advice, and is intended for informational and entertainment purposes only. Hosts and guests may hold positions in the companies and securities discussed; do your own research before acting on anything you hear